Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Tontonoz

Showing results (31-40 of 250) with videos related to

Pageof 25
Sort By:
Immunity|November 25, 2010
Licensing PPARγ to work in macrophagesClaudio J Villanueva, Peter Tontonoz
Cell|April 7, 2009
A Nurr1 pathway for neuroprotectionSteven J Bensinger, Peter Tontonoz
Current Atherosclerosis Reports|April 5, 2002
Orphan nuclear receptors find a home in the arterial wallBryan A Laffitte, Peter Tontonoz
Annual Review of Biochemistry|June 4, 2008
Fat and beyond: the diverse biology of PPARgammaPeter Tontonoz, Bruce M Spiegelman
Science Translational Medicine|September 10, 2010
Genome-wide association studies identify new targets in cardiovascular diseaseAnna C Calkin, Peter Tontonoz
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2010
Liver x receptor signaling pathways and atherosclerosisAnna C Calkin, Peter Tontonoz
Annual Review of Medicine|January 18, 2006
Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemiaSimon W Beaven, Peter Tontonoz
Life Metabolism|January 28, 2025
DIESL fuels a DGAT-independent triglyceride synthesis pathwayLauren F Uchiyama, Peter Tontonoz
Current Opinion in Pharmacology|April 12, 2003
LXRs: new therapeutic targets in atherosclerosis?Sean B Joseph, Peter Tontonoz
Atherosclerosis|July 13, 2015
Liver X receptors at the intersection of lipid metabolism and atherogenesisStephen D Lee, Peter Tontonoz
Pageof 25

Showing results (31-40 of 250) with videos related to

Sort By:
Pageof 25
Immunity|November 25, 2010
Licensing PPARγ to work in macrophagesClaudio J Villanueva, Peter Tontonoz
Cell|April 7, 2009
A Nurr1 pathway for neuroprotectionSteven J Bensinger, Peter Tontonoz
Current Atherosclerosis Reports|April 5, 2002
Orphan nuclear receptors find a home in the arterial wallBryan A Laffitte, Peter Tontonoz
Annual Review of Biochemistry|June 4, 2008
Fat and beyond: the diverse biology of PPARgammaPeter Tontonoz, Bruce M Spiegelman
Science Translational Medicine|September 10, 2010
Genome-wide association studies identify new targets in cardiovascular diseaseAnna C Calkin, Peter Tontonoz
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2010
Liver x receptor signaling pathways and atherosclerosisAnna C Calkin, Peter Tontonoz
Annual Review of Medicine|January 18, 2006
Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemiaSimon W Beaven, Peter Tontonoz
Life Metabolism|January 28, 2025
DIESL fuels a DGAT-independent triglyceride synthesis pathwayLauren F Uchiyama, Peter Tontonoz
Current Opinion in Pharmacology|April 12, 2003
LXRs: new therapeutic targets in atherosclerosis?Sean B Joseph, Peter Tontonoz
Atherosclerosis|July 13, 2015
Liver X receptors at the intersection of lipid metabolism and atherogenesisStephen D Lee, Peter Tontonoz
Pageof 25